Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications

Cancers 14 (2) 280.Jacquemin V., Antoine M., Dom G., Detours V., Maenhaut C., Dumont J.E. (2022)

Previous
Previous

Zebrafish Galectin 3 binding protein is the target antigen of the microglial 4C4 monoclonal antibody

Next
Next

Microglia states and nomenclature: A field at its crossroads